Home
About Us
About Us
Our Approach
Who we are
Careers
Imprint
Technologies
Microfluidics
Rabbit Mass Humanization
Single Copy Integration Site Technology
State-of-the-Art Antibody Discovery Technologies
Applications
ADCs
Binders
GPCRs
MHC-I/Peptide Complexes
Partnering
Media
Press Releases
Company Presentation
Contact
Media
Press Releases
January 3, 2024
Ampersand Biomedicines Acquires AbCheck to Accelerate Platform and Product Development
Download PDF
Our Services
Antibody
Discovery
Services
Antibody
Optimization
Services
Our Unique Platforms
Proprietary
Libraries
Technologies
Rabbit Mass
Humanization
Technologies
AbSieve®
Antibody
Selection
Technologies
AbAccel®
Antibody
Optimization
Technologies